Issue Type: Unraveling Payment Concepts
-
DPL, Commonwealth Fund and Health Affairs Release Policy Papers
Read More
-
CMS Changes Payment Policy for Drugs Purchased Through 340B
Read More
-
DPL Responds to CMS Proposed Changes to OPPS Policy
Read More
-
A $475,000 price tag for a new cancer drug: crazy or meh?
Read More
-
DPL and Collaborators to Publish Drug Pricing Primer Series
Read More
-
Is Outcomes-Based Contracting Worth It?
Read More
-
Bill to Kill CMS Drug Demo Gets Congressional Hearing
Read More
-
A Q&A with Peter Bach
Read More
-
Dr Steve Miller Highlights the Importance of Working Closely With Oncologists
Read More
-
Exclusive: Makers Took Big Price Increases on Widely Used U.S. drugs
Read More